Rajesh Nair

Rajesh Nair serves as Chief Executive Officer at Cryoviva Singapore. Cryoviva Singapore operates in the research sector with approximately 46.0 employees. The company is headquartered in Singapore.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • Our database includes 201,464 c suite-level executives.

Cloudflare DNS Gmail Google Apps Microsoft Office 365 Facebook Widget DoubleClick WordPress.org Apache Google Dynamic Remarketing Google Font API Google Tag Manager DoubleClick Conversion Facebook Custom Audiences reCAPTCHA Mobile Friendly Facebook Login (Connect) Python AI

stem cell banking & cord blood banking biotechnology research cord blood banking stem cell storage umbilical cord blood cord tissue banking global health presence clinical trials cord blood collection cord blood processing stem cell therapies aabb accredited customer care biomedical research healthcare solutions family cord blood bank cord blood testing blood cell donation stem cell innovation secured storage safety protocols stem cell treatment health assurance price options client testimonials medical expertise 24/7 emergency support medical professionals blood storage technology private banking public donation cord blood transplants cell processing technology bio-banking dna preservation stem cell potential international standards parent education knowledgeable consultants quality assurance medical integrity research & development emergency cord blood retrieval stem cell regeneration baby health solutions functionality testing customer satisfaction tracking health care health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Rajesh Nair in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Cryoviva Singapore.

Rajesh Nair's Position in the MessageCEO Database

• •Rajesh Nair is 1 of 1 verified executive contact we track at Cryoviva Singapore.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •24 verified contacts work at research companies in the 46.0 employee range (same size as Cryoviva Singapore).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated November 2026.

How do I reach Rajesh Nair directly?

Rajesh Nair's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at Cryoviva Singapore. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Rajesh Nair work for?

Rajesh Nair is Chief Executive Officer at Cryoviva Singapore, a company in the research sector with 46.0 employees. The company is based in Singapore.

Can I pitch or sell to Rajesh Nair?

As Chief Executive Officer at Cryoviva Singapore, Rajesh Nair is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Rajesh Nair directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Rajesh Nair in?

Rajesh Nair works in the research industry as Chief Executive Officer at Cryoviva Singapore. MessageCEO provides verified contact information for executives across all major industries.

Is Rajesh Nair's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Rajesh Nair's profile is kept up-to-date with the latest available information.

Last updated: November 9, 2026